Registered entities
Innovation
27 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 908 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 7 |
| 2024 | 19 |
| 2025 | 16 |
| 2026 | 7 |
Social engagement
Social engagement: 27.6K social following, 8 posts in the last 12 months — below the industry typical range.
Investor mix
23 investors on record; lead investors include Third Rock Ventures, Arch Venture Partners, City Hill Ventures, Matrix Capital Management; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 17 | 74% |
| Private equity | 1 | 4% |
| Bank & private debt | 2 | 9% |
| Other / undisclosed | 3 | 13% |
Hiring activity
Hires periodically
7 roles tracked across 5 of the last 12 months
9 Mar 2026 · Manager, Regulatory Affairs · South San Francisco
2 Mar 2026 · Senior Clinical Trial Specialist, CKD · South San Francisco
23 Feb 2026 · Director, Data Management · South San Francisco
9 Jan 2026 · Director, Clinical Sciences · South San Francisco
12 Sep 2025 · Director, Quality · South San Francisco
Based on job postings tracked across public sources.